Patents by Inventor GUILIANA MOGNOL

GUILIANA MOGNOL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED INTERLEUKIN 2 (IL-2) POLYPEPTIDES, AND METHODS OF MAKING AND USING THE SAME
    Publication number: 20240010697
    Abstract: This disclosure relates, inter alia to: modified interleukin 2 (IL-2) polypeptides; RNA polynucleotides, DNA polynucleotides, non-viral vectors, and viral vectors encoding such modified IL-2 polypeptides; methods of making such modified IL-2 polypeptides and RNA polynucleotides, DNA polynucleotides, non-viral vectors, and viral vectors encoding same; and methods of using such modified IL-2 polypeptides and RNA polynucleotides, DNA polynucleotides, non-viral vectors, and viral vectors encoding same.
    Type: Application
    Filed: October 13, 2021
    Publication date: January 11, 2024
    Applicant: CYTIMM THERAPEUTICS, INC.
    Inventors: HAINING HUANG, XIAO XU, YU FENG, GUILIANA MOGNOL, CAN JIN, DIANA GUIMET
  • Modified Interleukin 2 (IL-2) Polypeptides, Conjugates and Uses Thereof
    Publication number: 20220289806
    Abstract: This disclosure relates to modified interleukin 2 (IL-2) polypeptides, polynucleotides, e.g., DNA, RNA or viral vector, that encode the modified IL-2 polypeptides and are configured to express said modified IL-2 polypeptides in vitro and/or in vivo, conjugates comprising the modified IL-2 polypeptides, and uses thereof.
    Type: Application
    Filed: August 11, 2020
    Publication date: September 15, 2022
    Inventors: Xiao XU, Haining HUANG, YU FENG, GUILIANA MOGNOL, CAN JIN, DIANA GUIMET